சிஇஆர்டிஐஎஃப்ஐஇடி சேவை வழங்குநர் ப்ரோக்ர்யாம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சிஇஆர்டிஐஎஃப்ஐஇடி சேவை வழங்குநர் ப்ரோக்ர்யாம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சிஇஆர்டிஐஎஃப்ஐஇடி சேவை வழங்குநர் ப்ரோக்ர்யாம் Today - Breaking & Trending Today

Immunai Joins 10x To Scale Single Cell Genomics


Immunai Joins 10x To Scale Single Cell Genomics
December 21, 2020
By Allison Proffitt 
December 21, 2020 | Immunai has announced its collaboration with 10x Genomics as one of the first 10x Certified Service Providers. Immunai will leverage 10x’s robust single-cell technologies to map hundreds of cell types and states. By applying its proprietary artificial intelligence and machine learning algorithms, Immunai supports biomarker discovery and insight generation to ultimately power new therapeutic discoveries and accelerate drug development. 
Immunai was started by Luis Voloch and Noam Solomon about two years, Voloch told
Bio-IT World. The goal is to “revolutionize immunology” by scaling single cell genomics, he said, both in the lab and computationally.   ....

New York , United States , San Francisco , Tel Aviv , Brad Crutchfield , Allison Proffitt , Sloan Kettering , Luis Voloch , Certified Service Providers , Certified Service Provider Program , Baylor College Of Medicine , Certified Service , Noam Solomon , Human Cell Atlas , Memorial Sloan Kettering , Massachusetts General Hospital , Baylor College , Single Cell Immune Profiling , Chief Commercial Officer , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , சான் பிரான்சிஸ்கோ , தொலைபேசி அவிவ் , பிராட் கிருச்சபையில்ட் , அல்லிசன் ப்ரோப்பிட்ட் , ஸ்லோன் கெட்டரிங் ,

Collaboration to chart AI-generated map of the immune system


Collaboration to chart AI-generated map of the immune system
A partnership between Immunai and 10x Genomics will use artificial intelligence to create a map of the immune system to help accelerate drug development.
Immunai, a company specializing in comprehensive mapping of the human immune system, is joining forces with 10x Genomics. The latter will leverage its single-cell technologies to map hundreds of cell types and states. By applying its artificial intelligence (AI) and machine learning (ML) algorithms, Immunai supports biomarker discovery and insight generation to help power new therapeutic discoveries and accelerate drug development.
Outsourcing-Pharma (OSP) discussed the partnership with Luis Voloch (LV), CTO and co-founder of Immunai, and how the map generated through the collaborative effort stands to benefit drug developers. ....

United States , Certified Service Provider Program , Journal Of The American Medical Association , Luis Voloch , American Medical Association , ஒன்றுபட்டது மாநிலங்களில் , சிஇஆர்டிஐஎஃப்ஐஇடி சேவை வழங்குநர் ப்ரோக்ர்யாம் , இதழ் ஆஃப் தி அமெரிக்கன் மருத்துவ சங்கம் , அமெரிக்கன் மருத்துவ சங்கம் ,